Creation of a Drug Donation Program

Updated the publication status header from 'REREVISED' to 'REVISED' and adjusted the explanatory text regarding amendments adopted in the Second House.

Removed the '3rd Reading Unamended' date stamp and the House committee listing for Health & Human Services.

Removed several names from the House Sponsorship list (Bird, Boesenecker, Clifford, Duran, Feret, Garcia, Hamrick, Joseph, Lieder, Lindsay, Mabrey, McCluskie, Paschal, Rutinel, Rydin, Smith, Stewart K., Story, Titone, Willford).

Added new language permitting licensed facilities to return unused medications and medical devices to a pharmacist within the facility or a prescription drug outlet for redispensing to another patient or donation to a nonprofit entity or authorized practitioner.

Added a new subsection allowing licensed facilities or prescription drug outlets to donate materials to a nonprofit entity with legal authority to possess the materials.

Added '3rd Reading Unamended' and 'Amended 2nd Reading' status labels with dates to track legislative progress.

Expanded House sponsorship list to include 19 additional legislators (Sirota, Bird, Boesenecker, Clifford, Duran, Feret, Garcia, Hamrick, Joseph, Lieder, Lindsay, Mabrey, McCluskie, Paschal, Rutinel, Rydin, Smith, Stewart K., Story, Titone, Willford).

Removed 'PREAMENDED' and 'Unofficial Version' labels, replacing them with 'REREVISED' and 'All Amendments Adopted' designation.

Reformatted bill text with new line numbering and spacing adjustments for clarity.

Changed the definition of 'medication' to 'medicine' to mean prescription drugs rather than just prescriptions.

Expanded the definition of acceptable donations to include prescription drugs requiring refrigeration, freezing, or special storage if the cold chain can be verified.

Added requirement that donated medicine must first be dispensed to eligible patients who are indigent, uninsured, underinsured, or enrolled in public health benefits programs.

Added requirements for donation recipients to keep records of donated medicine, keep it separate from regular stock, and have it inspected by a licensed pharmacist.

Clarified that donation recipients may charge handling or dispensing fees but cannot resell the donated medicine for profit.

Corrected 'RIMS' to 'REMS' (Risk Evaluation and Mitigation Strategies) in references to federal drug safety requirements

Added note indicating the bill is prepared for signatures of legislative officers and the Governor

Minor formatting changes including capitalization corrections and text alignment throughout the document

Removed explanatory notes about how to read the bill markup (capital letters and bold numbers indicating new material)

Clarified that 'medicine' means prescription drugs and explicitly included prescription supplies and devices.

Added specific exclusions for compounded drugs, out-of-state pharmacy dispensed drugs, RIMS drugs without proper guidelines, and controlled substances.

Expanded eligibility to include individually packaged medicines and those requiring special storage if the cold chain is verified.

Added requirements that donated medicines must not be expired and must be in original, unopened, scaled, and tamper-evident unit dose packaging.

Added rules prohibiting resale of donated medicines and specifying that handling fees must not exceed the cost of providing the medicine for for-profit entities.

Strengthened liability protections by explicitly stating that good faith donations without negligence or willful misconduct are protected from civil or criminal liability.

Added new co-sponsors (Catlin, Frizell, Hinrichsen, Jodeh, Kipp, Michaelson Jenet, Sullivan, Wallace, Winter F.) to the Senate sponsorship list.

Updated amendment status dates from April 28, 2025 to April 29, 2025 to reflect the reengrossed version.

Changed the header from 'ENGROSSED' to 'REENGROSSED' to indicate the bill's current legislative status.

Changed the definition of 'medication' to 'medicine' and updated the definition of 'medicine' to more clearly include prescription drugs requiring special storage (refrigeration, freezing) if the cold chain can be verified, while removing references to investigational use drugs.

Updated the REMS (Risk Evaluation and Mitigation Strategies) reference to clarify that medicines subject to REMS can be donated if all required guidelines are followed, removing the previous reference to 'f(3)' and adding clarity about REMS drugs initially dispensed by a pharmacy.

Minor formatting and text cleanup changes throughout the document, including removing redundant phrases and adjusting spacing in the definitions section.